Sponsor or institution
Clinical trials and research at Hangzhou Sciwind Biosciences Co., Ltd.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Hangzhou Sciwind Biosciences Co., Ltd. that are recruiting, in China. By phase: Phase 3 (3), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Ecnoglutide vs placebo for obese adults with knee osteoarthritis | Phase 3 | Wuhan, Hubei | Recruiting | Jul 29, 2026 |
| Once-weekly XW003 injections for people with obesity and obstructive sleep apnea on PAP therapy | Phase 3 | Shanghai, Shanghai Municipality | Recruiting | Feb 25, 2026 |
| Weekly XW003 injections for people with obesity and obstructive sleep apnea not using PAP | Phase 3 | Beijing, Beijing Municipality | Recruiting | Feb 4, 2026 |
| Oral ecnoglutide tablets for weight management in Chinese adults with overweight or obesity | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Nov 21, 2025 |
All recruiting trials (4)
-
Ecnoglutide vs placebo for obese adults with knee osteoarthritis
This study tests whether weekly injections of ecnoglutide can help reduce pain and improve function in adults who are obese and have knee osteoarthritis.
-
Once-weekly XW003 injections for people with obesity and obstructive sleep apnea on PAP therapy
This trial will test whether once-weekly XW003 (ecnoglutide) injections help people with obesity and moderate-to-severe obstructive sleep apnea who are already using positive airway pressure therapy.
-
Weekly XW003 injections for people with obesity and obstructive sleep apnea not using PAP
This will see if once-weekly XW003 injections help adults with obesity and moderate-to-severe obstructive sleep apnea who are not using positive airway pressure (PAP) therapy.
-
Oral ecnoglutide tablets for weight management in Chinese adults with overweight or obesity
This trial will test whether daily or weekly oral ecnoglutide tablets help Chinese adults with overweight or obesity and are safe and well tolerated.
Quick answers
How many clinical trials run by Hangzhou Sciwind Biosciences Co., Ltd. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.